Original Contribution |
From the Departments of Physiology and Biophysics (B.M.W., R.S.K., C.C.E., K.A.P., R.M.P., P.P.d.T., R.J.S.) and Medicine, Section of Cardiology (B.M.W.), College of Medicine, University of Illinois at Chicago, Chicago, Ill; and the Department of Molecular Genetics, Biochemistry and Microbiology (M.M., J.O., D.F.W.), College of Medicine, University of Cincinnati, Cincinnati, Ohio. The current address for M. Muthuchamy is Department of Medical Physiology, Texas A&M University Health Science Center, College Station, Tex.
Correspondence to Beata M. Wolska, PhD, Department of Medicine, Section of Cardiology, College of Medicine (M/C 787), University of Illinois at Chicago, 840 S Wood St, Chicago, IL 60612-7323. E-mail bwolska{at}uic.edu
| Abstract |
|---|
|
|
|---|
Key Words: transgenic mice myocyte tropomyosin sarcomere thin filament
| Introduction |
|---|
|
|
|---|
An important and poorly understood function is how changes in Tm
isoform population or covalent phosphorylation affect
cardiac function. Moreover, the functional significance of a point
mutation in
-Tm (Asp175Asn), which is linked to familial
hypertrophic cardiomyopathy, is
unclear.8 9 10 All of these alterations involve changes in
the charge of Tm, an important aspect of its reaction with other
thin-filament proteins.11 Our hypothesis is that
modification of electrostatic interactions between Tm and actin and
between Tm and Tn affect myofilament activation and cardiac
dynamics.
Although substantial information on the in vitro properties of Tm
exists, only recently has it become possible to alter specifically the
isoform population of Tm in heart muscle with a transgenic (TG)
approach.12 13 In an initial series of experiments, it was
found that the exchange of
-Tm isoform with ß-Tm in the
myofilament lattice influenced dynamics of relaxation in
work-performing hearts12 and increased submaximal
thin-filament activation through Ca2+ and strong
crossbridges in skinned preparations.13 In the present
experiments, we used intact single cells isolated from TG mouse hearts
(TG-ß-Tm) and nontransgenic mouse hearts (NTG) to show that the
changes observed in the dynamics of contraction in whole-heart
preparations are intrinsic to the cells. To understand the mechanism of
these changes, we measured the ATPase rate and tension that was
generated by the myofilaments. Our results provide the first evidence
that the Tm isoform population modulates the dynamics of contraction
and relaxation of intact single myocytes.
| Materials and Methods |
|---|
|
|
|---|
-Tm were generated through essentially the same method
as TG-ß-Tm mice except that the coding sequence for the mouse
-Tm
cDNA was used instead of ß-Tm cDNA. Expression of the transgene was
driven by the murine
-myosin heavy chain promotor, which restricts
expression to the cardiac compartment. The mice demonstrated no gross
phenotypic abnormalities, no evidence of neonatal mortality, and no
histological evidence of abnormalities or
hypertrophy.12
Myocyte Isolation
Myocytes were isolated as described by Wolska and
Solaro.14 The animals were heparinized (5000 U/kg body
wt) and after 30 minutes, anesthetized with
pentobarbital sodium (50 mg/kg body wt IP). The hearts were quickly
removed and put into cold, nominally Ca2+-free
control solution of the following composition (in mmol/L): NaCl
133.5, KCl 4, NaH2PO4 1.2,
MgSO4 1.2, HEPES 10, and glucose 11. The pH of
the solution was adjusted with NaOH to 7.4. The ascending aorta was
cannulated, and the hearts were perfused by the Langendorff method at
37°C at a perfusion pressure of 60 cm of H2O
for 5 minutes with Ca2+-free control solution
that containing BSA (1 mg/mL). The hearts were then perfused with the
above solution that contained collagenase type I and II
(Worthington; 0.63 mg/mL) and 25 µmol/L
Ca2+ for 10 to 15 minutes. At the end of the
perfusion period, the hearts were removed and placed into a dish
with the control solution with 100 µmol/L
Ca2+. Ventricles were cut into small pieces and
placed in a 37°C water bath for 10 minutes during which time they
were gently triturated with a pipette. After 10 minutes, the cell
suspension was filtered through a fine-mesh screen and placed into
centrifuge tubes. The cells were allowed to settle for 3 to 5
minutes. Supernatant fraction was removed and the cells were
resuspended in a fresh control solution with 100 µmol/L
Ca2+. This procedure was repeated again. The
cells were stored in the control solution with 500 µmol/L
Ca2+ at room temperature (22°C to 23°C) until
used, usually within 3 to 5 hours.
Measurement of Intact Cell Shortening
After the cells were isolated, they were placed in a small
perfusion chamber mounted on the stage of an inverted microscope and
perfused with control solution that contained 1.0 mmol/L
Ca2+. The cells were field stimulated (0.5 Hz)
with platinum electrodes placed close to the myocytes. The cell image
was collected by the x40 Nikon objective and transmitted to a
multi-image module. Output from the camera was split to a VCR and to a
video edge detector, which was used to monitor cell length. Signals
from the video edge detector were connected to a TV monitor in which
the image of the cell was projected. The cell-length signal was
recorded on a Gould WindowGraf chart recorder and on a
computer.14
ATPase Activity Assay of Myofibrillar Preparations From the
Whole Heart
Cardiac myofibrils were prepared according to the methods of
Pagani and Solaro.15 Mice were anesthetized with
ether, and their hearts were quickly excised and placed in ice cold
buffer, pH 7.0, of the following concentrations (in mmol/L): MOPS
25.0, KCl 60.0 and MgCl2 2.5. Because of the low
yield of protein from a single mouse heart, 3 hearts were pooled per
preparation and the myofibrils were isolated with the aid of 1.0%
Triton X-100. Protein concentration was determined according to the
method of Lowry et al.16 The rate of ATP hydrolysis of
unloaded myofibrils was determined according to the method described by
Pagani and Solaro15 but was scaled down to one fourth of
its original volume because of the small amount of protein obtained
from the myofibrillar preparation. The reaction continued at 30°C for
10 minutes in a solution of the following composition (in mmol/L):
Mg2+ 1, MOPS 20, KCl 79.5,
MgATP2- 5, EGTA 1, and pCa (-log[Ca]), with
values that ranged from 8.0 to 4.875 at pH 7.0. The reaction was
stopped with trichloroacetic acid and inorganic phosphate that was
determined had been released as described by Carter and
Karl.17 The ionic composition of all solutions was
computed with an iterative computer program.18
Force and ATPase Activity Measurements of Skinned Fiber
Bundles
Measurements of the pCa-force relation at different sarcomere
lengths were performed on fiber bundles prepared as follows: Adult mice
were anesthetized with pentobarbital sodium (50 mg/kg body wt
IP), and hearts were quickly removed and put into cold high-relaxing
solution of the following composition (in mmol/L): KCl 53, EGTA
10, MOPS 20, free Mg2+ 1,
MgATP2- 5, creatine phosphate 12, and 10 IU/mL
creatine phosphokinase. The pH of the solution was adjusted to 7.0 with
KOH. The ionic strength of all solutions was 150 mmol/L. Papillary
muscles from the left ventricle were dissected, and small fiber bundles
150 to 200 µm in width and 4 to 5 mm in length were
prepared. Fiber bundles were mounted between a micromanipulator and a
force transducer with cellulose-acetate glue. Fibers were skinned for
30 minutes in high-relaxing solution that contained 1% Triton
X-100. A resting sarcomere length of 1.8, 2.0, and 2.4 µm was
established from laser diffraction patterns.19 Isometric
tension was recorded on a chart recorder. After skinning, the
fibers were initially washed in high-relaxing solution and then
sequentially bathed in low-relaxing solution followed by solutions of
varying pCa values (pCa range from 8.0 to 4.5). Compared with
high-relaxing solution, low-relaxing solution contained 0.1 mmol/L
EGTA. All solutions also contained the protease inhibitors
pepstatin A (2.5 µg/mL), leupeptin (1 µg/mL), and PMSF (50
µmol/L).
In a separate series of experiments, we simultaneously measured ATPase activity and steady-state force.20 21 Detergent extracted fiber bundles were prepared from left papillary muscle as described above and placed in a standard relaxing solution to which 1% vol/vol Triton X-100 was added. The composition of this standard relaxing solution was as follows(in mmol/L): Na2ATP 7.3, MgCl2 10.6, EGTA 20, creatine phospate 10, and BES 100. The pH of the solution was adjusted to 7.1 with KOH. The ionic strength was adjusted to 200 mmol/L with KCl. The preparations were left in this solution for 2 hours for complete extraction of membranes.
The skinned muscle was attached to a displacement generator (model
300B, Cambridge Technology) on one end and to a force transducer
element (AE 801, SensoNor) on the other end with aluminum T clips. The
natural frequency of the force transducer was
2 kHz. The muscle
preparation was transferred manually between several baths to expose
the muscle to the various solutions that were used in the present
study (Table
). The bath that was used for
the ATPase assay had quartz windows to allow transmission of near-UV
light (340 nm) for the measurement of NADH absorbance (see below). The
volume of this bath was 30 µL, and the bath was continuously stirred
by motor-driven vibration of a membrane positioned at the bottom of the
bath. The baths were milled in aluminum blocks (anodized) and mounted
on top of an aluminum base through which water was circulated to allow
temperature control of all solutions (20±1°C). The force and
displacement generator position (ie, muscle length) signals were
filtered at 1 kHz (corner frequency, slope -12 dB/oct). The NADH
absorbance signal was filtered at 1 Hz (corner frequency, slope -12
dB/oct). The data were recorded on a chart recorder and sampled
through an A/D converter on computer disk (Macintosh 7600, Apple).
Samples were collected at a rate of 5 per second for 5 minutes.
Sarcomere length of the preparation was measured in relaxing solution
by means of a He-Ne laser and set at 2.3 µm.
|
The ATPase activity of the skinned muscle was measured online by means
of an enzyme-coupled assay as described in detail
previously.20 21 Formation of ADP by the muscle was
stoichiometrically coupled first to the synthesis of pyruvate and ATP
from phosphoenolpyruvate, a reaction that is catalyzed by the enzyme
pyruvate kinase, and, subsequent to synthesis of lactate, a reaction
that is catalyzed by the enzyme lactate dehydrogenase and during which
NADH is oxidized to NAD+. The breakdown of NADH
was determined photometrically. The ratio of light intensity at 340 nm,
which is sensitive to the NADH concentration in the bath, and the light
intensity at 410 nm, which serves as a reference signal, was obtained
by means of an analog divider. After each recording in the
assay bath, the NADH absorbance signal was calibrated by multiple
injections of 0.25 nmol of ADP (0.025 µL of 10 mmol/L ADP
solution) with a stepper motor-controlled calibration pipette (World
Precission Instruments). With this method, the SE of the first time
derivative of the NADH absorbance signal, determined during a period of
20 seconds, corresponded to about 0.1 pmol/s. Because the isometric
ATPase activity during contractions at saturating calcium
concentrations typically amounted to 25 pmol/s, this translates to a
signal-to-noise ratio of
250 under these conditions. During
contractions at submaximal activation, in which the ATPase activity of
the skinned muscle was relatively low, a signal-to-noise ratio of at
least 25 was achieved by appropriately increasing the time the
preparation was activated.
Solutions Used for Simultaneous Force and ATPase
Activity Measurements
Three bathing solutions were used: a relaxing solution, a
preactivating solution with low calcium-buffering capacity, and an
activating solution. The composition of these solutions is shown in the
Table
. In addition, all solutions contained 0.9 mmol/L
NADH; 100 mmol/L BES; 5 mmol/L Na-azide; 10 mmol/L
phosphoenolpyruvate; 4 mg/mL pyruvate kinase (500 U/mg); 0.24 mg/mL
lactate dehydrogenase (870 U/mg); 10 µmol/L oligomycin B;
0.2 mmol/L
P1,P5-di(adenosine-5')
pentaphosphate; and 100 µmol/L leupeptin. The ionic strength of
the solutions was kept at 200 mmol/L by adding the appropriate
amount of potassium propionate. The pH was adjusted to 7.1 at 20°C
with KOH. The compositions were calculated by use of the methods
described by Fabiato and Fabiato.22 The free
Mg2+ and MgATP concentrations were calculated at
1 and 5 mmol/L, respectively. To achieve a range of free calcium
concentrations, activating and relaxing solutions were appropriately
mixed, assuming an apparent stability constant of the Ca-EGTA complex
of 10.6.58 All chemicals were of the highest purity
available (Sigma Chemical Co).
Experimental Protocol
During a series of measurements, the muscle was incubated in the
relaxing solution for 3 minutes, in the preactivating solution for 3
minutes, in the activating solution for
1 minute, and then returned
to the relaxing solution. Before the first activation-relaxation cycle,
sarcomere length in the preparation, as measured in relaxing solution,
was adjusted to 2.3 µm. Then, after an initial activation at a
saturating calcium concentration (pCa 4.3), sarcomere length was
readjusted to 2.3 µm. It was found that after this readjustment,
resting sarcomere length remained stable throughout the experiment.
Next, a second activation at the saturating Ca2+
was performed, which served as a first force and ATP consumption rate
reference. The next 5 to 6 contractures were performed at a range of
intermediate Ca2+ concentrations that also
included the relaxing solution (pCa 9). These measurements were then
followed by a final control contracture at saturating
Ca2+.
Gel Electrophoresis
SDS-PAGE was performed according to the method of
Laemmli.23 Proteins from isolated myofibrils or cells were
separated on 12.5% SDS gels. To quantify expression of ß-Tm, the
gels were scanned by densitometric analysis (Personal
Densitometer SI, Molecular Dynamics). Myofilament proteins were
identified by comigration with known standards.
Data Computation and Statistical Analysis
All results were presented as mean±SE. Data were
analyzed with Inplot software (GraphPad Software) and fitted to
a sigmoidal curve of variable slope to derive the
pCa50 (half-maximally activating pCa) and Hill
coefficient. The significance of differences between the means was
evaluated by the Student t test. A value of
P
0.05 was the criterion for significance.
| Results |
|---|
|
|
|---|
|
Figure 2
illustrates the results of
experiments in which we compared the extent of shortening and the
kinetics of twitch contraction and relaxation in single myocytes
isolated from the NTG and TG-ß-Tm mouse hearts. As summarized in
Figure 3
, compared with NTG myocytes,
TG-ß-Tm cells showed no change in the extent of shortening. We also
found no significant changes in cell length between NTG and TG-ß-Tm
hearts. However, a significantly reduced maximum rate of contraction
and relaxation existed. To determine the mechanisms of this decreased
rate of relaxation, we measured isometric force and ATPase rates of
myofilaments prepared from NTG and TG-ß-Tm mouse hearts. Results
presented in Figure 4A
indicate
that compared with controls, force generated by myofilaments from TG
hearts was more sensitive to Ca2+. The
pCa50 was 5.65±0.001 (n=7 from 4 different
hearts) for NTG preparations and 5.78±0.006 (n=9 from 6 different
hearts) for TG-ß-Tm preparations. Figure 4B
shows results of
experiments in which we measured
Ca2+-activated MgATPase activity of
unloaded myofibrils. We found no significant difference in maximum
ATPase activity between myofibrils prepared from NTG and TG-ß-Tm
mouse hearts. However, as in the case of force developed by skinned
fiber bundles,13 ATPase activity of myofibrils from
TG-ß-Tm mouse hearts was more sensitive to Ca2+
compared with NTG hearts. The pCa50 was
5.97±0.02 (n=21 from 7 preparations) for NTG myofibrils and 6.15±0.03
(n=13 from 5 preparations) for TG-ß-Tm. We also compared
simultaneous measurements of isometric force and ATPase
activity in skinned preparations prepared from NTG and TG-ß-Tm mouse
hearts at sarcomere length 2.3 µm. Figure 5
shows the relationship between average
steady-state force and pCa in both groups of animals.
Consistent with data presented in Figure 4A
, the
force of fiber bundles prepared from TG-ß-Tm mouse hearts was more
sensitive to Ca2+. The
pCa50 of the isometric force was 5.95±0.03 (n=9
from 4 different hearts) in NTG and 6.11±0.03 (n=9 from 4 different
hearts) in TG-ß-Tm mouse hearts. Myofilaments from TG-ß-Tm mouse
hearts also showed a significant decrease in cooperativity compared
with myofilaments from NTG hearts (Hill coefficient was 3.3±0.1 in NTG
and 2.2±0.1 in TG-ß-Tm hearts). Interestingly, TG-ß-Tm mouse
hearts also showed a significant decrease in maximum force (at pCa
4.30) when compared with NTG hearts. Maximum force was 47.7±4.4
mN/mm2 in NTG and 33.7±4.6
mN/mm2 in TG-ß-Tm mouse hearts. Figure 6
shows the relation between the
rate of ATP consumption by the skinned muscle preparation and the level
of average steady-state force. Myofilaments from both groups
demonstrated a rate of ATP consumption that was linearly correlated
with steady-state force regardless of Tm isoform population. In
addition, the slope of the tension-ATPase relationship was similar
between groups such that the data clustered close to a common line.
Therefore, we conclude that the economy of force maintenance
was not affected by Tm isoform composition.
|
|
|
|
|
To examine whether the isoform population of Tm influences
length-dependent activation of the myofilaments, we measured pCa-force
relations at sarcomere lengths 1.8 and 2.4 µm. The shift in
pCa50 caused by changing the sarcomere length was
not significantly different between NTG and TG-ß-Tm fiber
preparations. The
pCa50 was 0.12±0.01 (n=5
from 3 different hearts) for NTG and 0.14±0.03 (n=7 from 5 different
hearts) for TG-ß-Tm preparations.
As a control experiment for ß-Tm overexpression, we overexpressed
native
-Tm and measured isometric force of myofilaments prepared
from TG-
-Tm mouse hearts and their litter mates (Figure 7
). The pCa-force relationship was
identical in both groups. The pCa50 was
5.74±0.03 (n=7 from 4 different hearts) in NTG and 5.73±0.02 (n=6
from 3 different hearts) in TG-
-Tm mouse hearts. Hill coefficient
was 3.55±0.12 in NTG and 3.33±0.22 in TG-
-Tm mouse hearts.
|
| Discussion |
|---|
|
|
|---|
-Tm with ß-Tm (1) slows the kinetics of
contraction and relaxation of single intact isolated myocytes, (2)
reduces maximum tension developed by the myofilaments, (3) shifts
pCa50 of the pCa-ATPase activity and pCa-force
relation to lower Ca2+, and (4) does not alter
length-dependent myofilament activation. Important questions that we
address here are (1) What are the mechanisms responsible for the
observed increase in Ca2+ sensitivity and
decrease in maximum force and ATPase activity associated with replacing
myofilament
-Tm with ß-Tm and (2) What are the mechanisms
responsible for depressed rates of contraction and relaxation in single
myocytes from TG-ß-Tm mouse hearts when compared with NTG?
A plausible mechanism for the increase in Ca2+
sensitivity of myofilaments from TG-ß-Tm hearts is charge-dependent
differences between the affinity of
-Tm and ß-Tm for their
neighbors on the thin filament. Switching from native
-Tm to ß-Tm,
in which Ser229
Glu, and His276
Asn
involves a -2 charge change.24 These charge changes are
likely to affect Tm interactions with TnT and actin.11 25
The Tm-coiled coil possesses repeating motifs of charged and uncharged
residues that react with actin and most likely TnT through nonspecific
ionic mechanisms. Charged side chains of Tm are mobile and accessible
for binding to neighboring protein. This design of Tm provides
versatile and flexible interactions with the thin filament and would be
expected to be perturbed by charge changes. For example, Golitsina et
al26 have shown that
-Tm with a point mutation
(Asp175Asn) linked to familial hypertrophic
cardiomyopathy binds more weakly to actin than wild
type
-Tm. Of course, the functional differences between the TG and
NTG myofilaments reported could well be due to other amino acid
substitutions that occur when switching from ß-Tm to
-Tm.
What are the mechanisms responsible for depressed rates of contraction and relaxation in single myocytes from TG-ß-Tm mouse hearts when compared with NTG? This difference does not appear to arise from differences in the rate of crossbridge detachment, the limiting step of the crossbridge cycle. Our data obtained from the simultaneous determination of tension and ATPase rate indicate that tension is proportional to ATPase rate regardless of the Tm isoform in the myofilaments. A slower rate of relaxation could arise from the increased Ca2+ sensitivity of the myofilaments with no change in the rate of Ca2+ transport by the sarcoplasmic reticulum and Na-Ca exchanger.
Yet, according to the model of Campbell,27 the development of force is slowed by a cooperative action of force-generating crossbridges feeding back on activation. Because myofilaments that contain ß-Tm are more sensitive to activation by strong crossbridges,13 the Campbell model predicts a slower rate of force development in preparations from TG-ß-Tm hearts. The Campbell model also predicts that the cooperative feedback of force-generating crossbridges is more pronounced at low levels of Ca2+ activation, a condition that most likely exists during the basal activity of intact cells studied in this experiment. The increased cooperative action of force-generating crossbridges is additionally associated with an increase in pCa50, which agrees with our data from skinned fiber bundles.
Our results from studies of isolated cardiomyocytes are in agreement with results of previous studies that compared in vitro work-performing hearts of NTG and TG-ß-Tm mice.12 Although cells isolated from TG-ß-Tm mouse hearts showed the same extent of shortening as cells isolated from control mice, these cells demonstrated significant differences in the dynamics of contraction and relaxation. The decreased rate of relaxation of myocytes corresponds to decreased -dP/dtmax and the time to half relaxation in work-performing hearts. In cells isolated from TG-ß-Tm mouse hearts, we also observed a small (36%) but significant decrease in the maximum rate of contraction, despite no change in the maximum rate of contraction (dP/dtmax) in work-performing hearts. This difference in results obtained from studies with isolated myocytes and with work-performing hearts may be due to the different loads (essentially 0 for cells) against which these preparations contract. Moreover, our experiments were performed at room temperature, whereas experiments with work-performing hearts were performed at 35°C.
Our investigation of the length dependence of myofilament
Ca2+ activation showed that myofilaments that
contained predominantly
-Tm and myofilaments that contained
predominantly ß-Tm demonstrated the same shift in
pCa50 with changes in sarcomere length. We
conclude from these results that differences in sarcomere length
dependence of activation among different muscle types are not likely to
be due to differences in the isoform population of Tm. The mechanism of
length dependent activation is in dispute, but it is apparent that an
important aspect of the mechanism is mediated by changes in
interfilament spacing associated with changes in sarcomere
length.28 29 30 The idea here is that the crossbridge
reaction is promoted when the filaments are closer together and
depressed when the filaments are farther apart. Thus, at a particular
pCa value, force will rise or fall depending on interfilament spacing
and give rise to shifts in the pCa-force relations. The mechanism
appears to be modulated by fiber type variations in the activation
state of the thin filament induced by the bound crossbridges. For
example, recent results of McDonald et al31 that show
differential effects of length on Ca2+ activation
of slow versus fast skeletal muscle fibers were interpreted on the
basis of a greater ability of strongly bound crossbridges to induce
activation in the fast muscle fibers. Yet, it is apparent in our
experiments that differences in cooperativity between
-Tm and ß-Tm
that contained myofilament were not sufficient to account for the
differences in length-dependent activation. Other factors that could
play a role are differences in the TnI and TnT isoform population.
Differences in TnC isoforms probably do not account for differences in
length-dependent activation.32
Our data show that although Ca2+ sensitivity in
fiber bundles that contain ß-Tm is increased, the maximum number of
force-generating crossbridges is depressed, as reflected in the reduced
tension at maximum free Ca2+. These results
indicate that the Ca2+-dependent transition to
the "open" state of Tm is eased in fiber bundles that contain
ß-Tm, whereas the maximum level of thin-filament activation is
depressed. At maximum levels of free Ca2+, we
would expect TnC to be fully saturated; thus, Tm open state would
depend on crossbridge interaction with the thin filament. It is
apparent that the ability of strongly bound force generating
crossbridges to fully active the thin filament is depressed in fiber
bundles in which ß-Tm has replaced
-Tm.
We conclude from our results that TG mouse hearts with myofilaments
having an increased population of the ß-Tm isoform demonstrate
altered dynamics due to changes that are intrinsic to the myocytes and
are mainly caused by charge differences between
-Tm and ß-Tm. We
think that changes in dynamics result from either increased sensitivity
of myofilament force and ATPase to Ca2+ or
altered feedback effects of force bearing crossbridges on activation.
Our results may also have important implications for better
understanding of the etiology of familial hypertrophic
cardiomyopathy linked to point mutation of
-Tm.
| Acknowledgments |
|---|
Received April 27, 1998; accepted January 19, 1999.
| References |
|---|
|
|
|---|
2. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol. 1996;58:447481.[Medline] [Order article via Infotrieve]
3. Lehman W, Craig R, Vibert P. Ca2+-induced tropomyosin movement in Limulus thin filaments revealed by three-dimensional reconstruction. Nature. 1994;368:6567.[Medline] [Order article via Infotrieve]
4. Lehman W, Vibert P, Uman P, Craig R. Steric-blocking by tropomyosin visualized in relaxed vertebrate muscle thin filaments. J Mol Biol. 1995;251:191196.[Medline] [Order article via Infotrieve]
5. Lehrer SS. The regulatory switch of the muscle thin filament: Ca2+ or myosin heads? J Muscle Res Cell Motil. 1994;15:232236.[Medline] [Order article via Infotrieve]
6.
Pan BS, Gordon AM, Luo Z. Removal of tropomyosin
overlap modifies cooperative binding of myosin S-1 to reconstituted
thin filaments of rabbit striated muscle. J Biol Chem. 1989;264:84958498.
7. Lehrer SS, Golitsina NL, Geeves MA. Actin-tropomyosin activation of myosin subfragment 1 ATPase and thin filament cooperativity: the role of tropomyosin flexibility and end-to-end interactions. Biochemistry. 1997;36:1344913454.[Medline] [Order article via Infotrieve]
8. Muthuchamy M, Rethinasamy P, Wieczorek DF. Tropomyosin structure and function: new insights. Trends Cardiovasc Med. 1997;7:124128.
9. Nakajima-Taniguchi C, Matsui H, Nagata S, Kishimoto T, Yamauchi-Takihara K. Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 1995;27:20532058.[Medline] [Order article via Infotrieve]
10.
Thierfelder L, Watkins H, MacRae C, Lamas R, Mckenna W,
Vosberg HP, Seidman JG, Seidman CE.
-Tropomyosin and cardiac
troponin T mutations cause familial hypertrophic
cardiomyopathy: a disease of the sarcomere.
Cell. 1994;77:701712.[Medline]
[Order article via Infotrieve]
11. Lorenz M, Poole KJ, Popp D, Rosenbaum G, Holmes KC. An atomic model of the unregulated thin filament obtained by X-ray fiber diffraction on oriented actin-tropomyosin gels. J Mol Biol. 1995;246:108119.[Medline] [Order article via Infotrieve]
12.
Muthuchamy M, Grupp IL, Grupp G, OToole BA, Kier AB,
Boivin GP, Neumann J, Wieczorek DF. Molecular and
physiological effects of overexpressing striated
muscle beta-tropomyosin in the adult murine heart. J Biol
Chem. 1995;270:3059330603.
13.
Palmiter KA, Kitada Y, Muthuchamy M, Wieczorek DF,
Solaro RJ. Exchange of ß- for
-tropomyosin in hearts of TG
mice induces changes in thin filament response to
Ca2+, strong cross-bridge binding, and protein
phosphorylation. J Biol Chem. 1996;271:1161111614.
14. Wolska BM, Solaro RJ. Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am J Physiol. 1996;40:H1250H1255.
15. Pagani ED, Solaro RJ. Methods for measuring functional properties of sarcoplasmic reticulum and myofibrils in small samples of myocardium. In: Schwartz A, ed. Methods in Pharmacology. New York, NY: Plenum Publishing Corp; 1984:4961.
16. Lowry DH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:165175.
17. Carter SG, Karl DW. Inorganic phosphate assay with malachite green: an improvement and evaluation. J Biochem Biophys Methods. 1982;7:713.[Medline] [Order article via Infotrieve]
18.
Godt RE, Lindley BD. Influence of temperature upon
contractile activation and isometric force production in
mechanically skinned muscle fibers of the frog. J Gen
Physiol. 1982;80:279297.
19.
Hibberd MG, Jewell BR. Calcium- and length-dependent
force production in rat ventricular muscle.
J Physiol (Lond). 1982;329:527540.
20. Stienen GJ, Papp Z, Elzinga G. Calcium modulates the influence of length changes on the myofibrillar adenosine triphosphatase activity in rat skinned cardiac trabeculae. Pflugers Arch. 1993;425:199207.[Medline] [Order article via Infotrieve]
21.
de Tombe PP, Stienen GJ. Protein kinase A does not
alter economy of force maintenance in skinned rat cardiac
trabeculae. Circ Res. 1995;76:734741.
22. Fabiato A, Fabiato F. Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol (Paris). 1979;75:463505.[Medline] [Order article via Infotrieve]
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680685.[Medline] [Order article via Infotrieve]
24.
Mak AS, Smillie LB, Stewart GR. A comparison of the
amino acid sequences of rabbit skeletal muscle
- and
ß-tropomyosins. J Biol Chem. 1980;255:36473655.
25. McLachlan AD, Stewart M. The 14-fold periodicity in alpha-tropomyosin and the interaction with actin. J Mol Biol. 1976;103:271298.[Medline] [Order article via Infotrieve]
26. Golitsina N, An Y, Greenfield NJ, Thierfelder L, Iizuka K, Seidman JG, Seidman CE, Lehrer SS, Hitchcock-DeGregori SE. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function. Biochemistry. 1997;36:46374642.[Medline] [Order article via Infotrieve]
27. Campbell K. Rate constant of muscle force redevelopment reflects cooperative activation as well as cross-bridge kinetics. Biophys J. 1997;72:254262.[Medline] [Order article via Infotrieve]
28. Fuchs F, Wang YP. Sarcomere length versus interfilament spacing as determinants of cardiac myofilament Ca2+ sensitivity and Ca2+ binding. J Mol Cell Cardiol. 1996;28:13751383.[Medline] [Order article via Infotrieve]
29.
McDonald KS, Moss RL. Osmotic compression of single
cardiac myocytes eliminates the reduction in Ca2+
sensitivity of tension at short sarcomere length. Circ Res. 1995;77:199205.
30. Wang YP, Fuchs F. Osmotic compression of skinned cardiac and skeletal muscle bundles: effects on force generation, Ca2+ sensitivity and Ca2+ binding. J Mol Cell Cardiol. 1995;27:12351244.[Medline] [Order article via Infotrieve]
31.
McDonald KS, Wolff MR, Moss RL. Sarcomere length
dependence of the rate of tension redevelopment and submaximal tension
in rat and rabbit skinned skeletal muscle fibres. J Physiol
(Lond). 1997;501:607621.
32.
McDonald KS, Field LJ, Parmacek MS, Soonpaa M, Leiden
JM, Moss RL. Length dependence of Ca2+
sensitivity of tension in mouse cardiac myocytes expressing skeletal
troponin C. J Physiol (Lond). 1995;483:131139.
This article has been cited by other articles:
![]() |
G. Jagatheesan, S. Rajan, E. M. Schulz, R. P. H. Ahmed, N. Petrashevskaya, A. Schwartz, G. P. Boivin, G. M. Arteaga, T. Wang, Y.-G. Wang, et al. An internal domain of {beta}-tropomyosin increases myofilament Ca2+ sensitivity Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H181 - H190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ochala, M. Li, M. Ohlsson, A. Oldfors, and L. Larsson Defective regulation of contractile function in muscle fibres carrying an E41K {beta}-tropomyosin mutation J. Physiol., June 15, 2008; 586(12): 2993 - 3004. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, G. M. Arteaga, R. John Solaro, S. B. Liggett, and D. F. Wieczorek Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H949 - H958. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajan, R. P.H. Ahmed, G. Jagatheesan, N. Petrashevskaya, G. P. Boivin, D. Urboniene, G. M. Arteaga, B. M. Wolska, R. J. Solaro, S. B. Liggett, et al. Dilated Cardiomyopathy Mutant Tropomyosin Mice Develop Cardiac Dysfunction With Significantly Decreased Fractional Shortening and Myofilament Calcium Sensitivity Circ. Res., July 20, 2007; 101(2): 205 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ochala, M. Li, H. Tajsharghi, E. Kimber, M. Tulinius, A. Oldfors, and L. Larsson Effects of a R133W beta-tropomyosin mutation on regulation of muscle contraction in single human muscle fibres J. Physiol., June 15, 2007; 581(3): 1283 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vahebi, A. Ota, M. Li, C. M. Warren, P. P. de Tombe, Y. Wang, and R. J. Solaro p38-MAPK Induced Dephosphorylation of {alpha}-Tropomyosin Is Associated With Depression of Myocardial Sarcomeric Tension and ATPase Activity Circ. Res., February 16, 2007; 100(3): 408 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Engel, T. Kobayashi, B. Biesiadecki, J. Davis, S. Tikunova, S. Wu, and R. J. Solaro Identification of a Region of Troponin I Important in Signaling Cross-bridge-dependent Activation of Cardiac Myofilaments J. Biol. Chem., January 5, 2007; 282(1): 183 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Gaffin, K. Gokulan, J. C. Sacchettini, T. E. Hewett, R. Klevitsky, J. Robbins, V. Sarin, D. C. Zawieja, G. A. Meininger, and M. Muthuchamy Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H552 - H563. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Szczesna-Cordary, G. Guzman, J. Zhao, O. Hernandez, J. Wei, and Z. Diaz-Perez The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice J. Cell Sci., August 15, 2005; 118(16): 3675 - 3683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D Gaffin, C. W Tong, D. C Zawieja, T. E Hewett, R. Klevitsky, J. Robbins, and M. Muthuchamy Charged residue alterations in the inner-core domain and carboxy-terminus of {alpha}-tropomyosin differentially affect mouse cardiac muscle contractility J. Physiol., December 15, 2004; 561(3): 777 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, G. Arteaga, P. P. de Tombe, R. J. Solaro, and D. F. Wieczorek Physiological significance of troponin T binding domains in striated muscle tropomyosin Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1484 - H1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Moss, M. Razumova, and D. P. Fitzsimons Myosin Crossbridge Activation of Cardiac Thin Filaments: Implications for Myocardial Function in Health and Disease Circ. Res., May 28, 2004; 94(10): 1290 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Gaffin, K. Gokulan, J. C. Sacchettini, T. Hewett, R. Klevitsky, J. Robbins, and M. Muthuchamy Charged residue changes in the carboxy-terminus of {alpha}-tropomyosin alter mouse cardiac muscle contractility J. Physiol., April 15, 2004; 556(2): 531 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. McMullen, T. Shioi, W.-Y. Huang, L. Zhang, O. Tarnavski, E. Bisping, M. Schinke, S. Kong, M. C. Sherwood, J. Brown, et al. The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110{alpha}) Pathway J. Biol. Chem., February 6, 2004; 279(6): 4782 - 4793. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Marston and C. S. Redwood Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins: Physiological and Pathological Implications Circ. Res., December 12, 2003; 93(12): 1170 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, S. Vahebi, P. DeTombe, R. J. Solaro, E. Labitzke, G. Hilliard, et al. Functional Importance of the Carboxyl-terminal Region of Striated Muscle Tropomyosin J. Biol. Chem., June 13, 2003; 278(25): 23204 - 23211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Diffee, E. A. Seversen, T. D. Stein, and J. A. Johnson Microarray expression analysis of effects of exercise training: increase in atrial MLC-1 in rat ventricles Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H830 - H837. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pieples, G. Arteaga, R. J. Solaro, I. Grupp, J. N. Lorenz, G. P. Boivin, G. Jagatheesan, E. Labitzke, P. P. deTombe, J. P. Konhilas, et al. Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca2+ activation Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1344 - H1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Martin, R. M. Phillips, A. Kumar, K. Crawford, Z. Abbas, J. L. Lessard, P. de Tombe, and R. J. Solaro Ca2+ activation and tension cost in myofilaments from mouse hearts ectopically expressing enteric gamma -actin Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H642 - H649. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Wolska, G. M. Arteaga, J. R. Pena, G. Nowak, R. M. Phillips, S. Sahai, P. P. de Tombe, A. F. Martin, E. G. Kranias, and R. J. Solaro Expression of Slow Skeletal Troponin I in Hearts of Phospholamban Knockout Mice Alters the Relaxant Effect of {beta}-Adrenergic Stimulation Circ. Res., May 3, 2002; 90(8): 882 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. MacGowan, C. Du, D. F. Wieczorek, and A. P. Koretsky Compensatory changes in Ca2+ and myocardial O2 consumption in beta -tropomyosin transgenic hearts Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2539 - H2548. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M Wolska, K. Vijayan, G. M Arteaga, J. P Konhilas, R. M Phillips, R. Kim, T. Naya, J. M Leiden, A. F Martin, P. P de Tombe, et al. Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions J. Physiol., November 1, 2001; 536(3): 863 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Patel, D. P. Fitzsimons, S. H. Buck, M. Muthuchamy, D. F. Wieczorek, and R. L. Moss PKA accelerates rate of force development in murine skinned myocardium expressing {alpha}- or {beta}-tropomyosin Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2732 - H2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huang, B. M. Wolska, D. E. Montgomery, E. M. Burkart, P. M. Buttrick, and R. J. Solaro Increased contractility and altered Ca2+ transients of mouse heart myocytes conditionally expressing PKC{beta} Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1114 - C1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Keller, S.-Y. Shai, C. J. Babbitt, C. G. Pham, R. J. Solaro, M. L. Valencik, J. C. Loftus, and R. S. Ross Disruption of Integrin Function in the Murine Myocardium Leads to Perinatal Lethality, Fibrosis, and Abnormal Cardiac Performance Am. J. Pathol., March 1, 2001; 158(3): 1079 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chandra, V. L. M. Rundell, J. C. Tardiff, L. A. Leinwand, P. P. de Tombe, and R. J. Solaro Ca2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H705 - H713. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P Fitzsimons, J. R Patel, and R. L Moss Cross-bridge interaction kinetics in rat myocardium are accelerated by strong binding of myosin to the thin filament J. Physiol., January 15, 2001; 530(2): 263 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Evans, J. R. Pena, R. M. Phillips, M. Muthuchamy, D. F. Wieczorek, R. J. Solaro, and B. M. Wolska Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2414 - H2423. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M Arteaga, K. A Palmiter, J. M Leiden, and R J. Solaro Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I J. Physiol., August 1, 2000; 526(3): 541 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Moss and J. S.’A. Periera Enhanced Myosin Function Due to a Point Mutation Causing a Familial Hypertrophic Cardiomyopathy Circ. Res., April 14, 2000; 86(7): 720 - 722. [Full Text] [PDF] |
||||
![]() |
R. L. Moss Plasticity in the Dynamics of Myocardial Contraction : Ca2+, Crossbridge Kinetics, or Molecular Cooperation Circ. Res., April 16, 1999; 84(7): 862 - 865. [Full Text] [PDF] |
||||
![]() |
O. Cazorla, Y. Wu, T. C. Irving, and H. Granzier Titin-Based Modulation of Calcium Sensitivity of Active Tension in Mouse Skinned Cardiac Myocytes Circ. Res., May 25, 2001; 88(10): 1028 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Wolska, G. M. Arteaga, J. R. Pena, G. Nowak, R. M. Phillips, S. Sahai, P. P. de Tombe, A. F. Martin, E. G. Kranias, and R. J. Solaro Expression of Slow Skeletal Troponin I in Hearts of Phospholamban Knockout Mice Alters the Relaxant Effect of {beta}-Adrenergic Stimulation Circ. Res., May 3, 2002; 90(8): 882 - 888. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |